By Topic

Evaluation of Portal/Peripheral Route and of Algorithms for Insulin Delivery in the Closed-Loop Control of Glucose in Diabetes - A Modeling Study

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$33 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

2 Author(s)
Claudio Cobelli ; Istituto di Elettrotecnica e di Elettronica, Universitàdi Padova, 35100 Padova, Italy, and LADSEB-CNR ; Alfredo Ruggeri

In this paper we present an evaluation of portal versus peripheral routes for insulin delivery in diabetes with three representative closed-loop glucose control algorithms. A novel noninvasive approach is used which is based on a model of the blood glucose regulation system which simulates a Type I diabetic subject. The two routes and three algorithms are compared in controlling the simulated patient for 24 h, challenged with two dynamic glucose perturbations. The evaluation is performed by comparing both plasma accessible variables (e.g., glucose and insulin) and metabolic fluxes (e.g., glucose production and uptake, peripheral glucose utilization). Similar performances are achieved by the three algorithms both with peripheral and with portal infusions, especially in the postabsorptive steady state. An almost complete metabolic normalization is obtained with the portal route. With the peripheral route, normality is not restored; in particular, hyperinsulinemia and enhanced insulin-dependent glucose utilization are produced. From these simulation results, it is the site of insulin infusion, which appears to play an essential role in terms of the ability to normalize the metabolic state of a diabetic subject.

Published in:

IEEE Transactions on Biomedical Engineering  (Volume:BME-30 ,  Issue: 2 )